|
Research And Markets - Lack Of Necessary Research Resources Can Lead To The Failure Of Pharmaceutical Brand Teams To Complete Their Most Important Tasks
Research and Markets (researchandmarkets.com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.
(PRWEB) November 18, 2004 -- Market research is such an integral part of the strategic process for pharmaceutical brand teams that few major decisions are made without some support data. At the same time, market research teams often lack the necessary resources to accomplish some of their most important tasks during product development. This study highlights common resource gaps in pharmaceutical market research groups, along with identifying tactics to elevate the strategic impact of this very important function.
Research and Markets (http://www.researchandmarkets.com/reports/c9391) has announced the addition of Pharmaceutical Market Research: Decision Support for Brand Growth to their offering.
The most successful market research teams maintain a keen awareness of industry trends at all times. To truly impact brand strategy, these market research teams get involved from the outset and help position products well ahead of Launch. By combining solid activity planning and adequate resources, market research groups can often be the driving factor in major go/no-go decisions.
Several components contribute to a strong market research plan:
- Structure & Investment -- Average market research spending remained the same over the last three years, but companies have favoured higher early-stage investments.
- Strategy Development -- Market research strategy development begins with overall brand goals. Research groups must function as part of the brand team every step of the way.
- Activity Coordination -- Even companies with low market research budgets can compete with large products if they know how to coordinate their activities.
The companies mentioned in this report are as follows:
- Alcon Labs
- AstraZeneca
- Aventis Pasteur
- Bayer
- Biopedal
- Bristol-Myers Squibb
- Eli Lilly
- EMD Pharmaceuticals
- Merck KGaA
- Schering AG
- Novartis
- Pfizer
- Procter and Gamble Pharmaceuticals
- Roche
- Sanofi-Aventis
- Schering-Plough
- Schwarz Pharma
- Theratechnologies
- Wyeth
For more information visit http://www.researchandmarkets.com/reports/c9391
Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980
###
|